Projects
Gut functional and inflammatory disorders: biomarker and therapeutic target discovery (GUT-FIRE) KU Leuven
Validation of autophagy induction as a therapeutic strategy: from drug discovery and preclinical evaluation to safety investigation and biomarker research. University of Antwerp
IMARK. Network for image-based biomarker discovery and evaluation University of Antwerp
ADMIRE: Association, causality and biomarker Discovery in translational MIcrobiome REsearch. Hasselt University
Improving treatment strategies for different depressive disorders by discovery of novel drug target candidates and discriminatory diagnostic biomarkers. University of Antwerp
ORDECA – ORganoid Drug screening for Endometrial CAncerIdentifying novel drugs and biomarkers for treating endometrial cancer using a high-throughput patient-derived organoid drug discovery and screening platform KU Leuven
Discovery of renal biomarkers to detect early chronic kidney disease in cats Ghent University
This research project aims to identify novel diagnostic and prognostic biomarkers for the early detection of feline chronic kidney disease (CKD). CKD is a frequently encountered disease in veterinary practices, affecting at least 30% of cats over 15 years of age. Current diagnostic tests only detect CKD once there is extensive damage, so it is of significant clinical and commercial importance to diagnose CKD at an earlier stage. This way, ...
Discovery of metabolite biomarkers for early diagnosis and prognosis of cow's milk allergy in children Ghent University
Cow’s milk allergy (CMA) is one of the most prevalent and first food allergies to occur in early
childhood. Diagnosis of CMA currently relies on challenge-based tests, which have to be repeated
on a yearly basis to assess possible spontaneous resolution. These tests inherently result in allergic
reactions in patients. As metabolites represent the total contribution of genomic, transcriptomic
and proteomic activities, ...